- 1) Lee JS and Surh YJ, Cancer Lett., 224, 171–184 (2005).
- 2) Marrot L, Jones C, Perez P, and Meunier JR, Pigment Cell Melanoma Res., 21, 79–88 (2008).
- 3) Zhu H, Jia Z, Strobl JS, Ehrich M, Misra HP, and Li Y, Cardiovasc. Toxicol., 8, 115–125 (2008).
- 4) Kim BR, Hu R, Keum YS, Hebbar V, Shen G, Nair SS, and Kong AN, Cancer Res., 63, 7520–7525 (2003).
- 5) Ono H, Adachi K, Fuke Y, and Shinohara K, Nippon Shokuhin Kagaku Kôgaku Kaishi (in Japanese), 43, 1092–1097 (1996).
- 6) Hou D-X, Fukuda M, Fujii M, and Fuke Y, Cancer Lett., 161, 195–200 (2000).
- 7) Ryoyama K, Mori N, Nara M, Kidachi Y, Yamaguchi H, Umetsu H, and Fuke Y, Anticancer Res., 23, 3741–3748 (2003).
- 8) Ryoyama K, Kidachi Y, Yamaguchi H, Kajiura H, and Takata H, Biosci. Biotechnol. Biochem., 68, 2332–2340 (2004).
- 9) Catarzi S, Degl’Innocenti D, Iantomasi T, Favilli F, and Vincenzini MT, Cell. Mol. Life Sci., 59, 1388–1394 (2002).
- 10) Yang Y, Dieter MZ, Chen Y, Shertzer HG, Nebert DW, and Dalton TP, J. Biol. Chem., 277, 49446–49452 (2002).
- 11) Xu K and Thornalley PJ, Biochem. Pharmacol., 61, 165–177 (2001).
- 12) Carmichael J, DeGraff WG, Gazdar AF, Minna JD, and Mitchell JB, Cancer Res., 47, 943–946 (1987).
- 13) Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren J, Bokesch H, Kenney S, and Boyd MR, J. Natl. Cancer Inst., 82, 1107–1112 (1990).
- 14) Yamaguchi H, Noshita T, Kidachi Y, Umetsu H, Fuke Y, and Ryoyama K, Chem. Pharm. Bull., 56, 715–719 (2008).
Bioscience, Biotechnology, and Biochemistry
Volume 73, 2009 - Issue 6